Viewing Study NCT03618602


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-01-12 @ 1:03 PM
Study NCT ID: NCT03618602
Status: UNKNOWN
Last Update Posted: 2019-09-19
First Post: 2018-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients
Sponsor: Shanghai Theorion Pharmaceutical Co Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module